We could not find any results for:
Make sure your spelling is correct or try broadening your search.
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical to... One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales. Show more
Medtronic receives FDA approval for Inceptivโข closed-loop spinal cord stimulator PR Newswire DUBLIN, April 26, 2024 Closed-loop sensing capability instantly and automatically adjusts therapy...
Americans favor quality over quantity in pursuit of longevity PR Newswire DUBLIN, April 17, 2024 According to a new survey from Medtronic and Morning Consult, nearly two-thirds of U.S. adults say...
Medtronic unveils the future of AI in GI: Genius Summit 2024 reveals innovations and collaborations that advance endoscopic care PR Newswire DUBLIN, April 10, 2024 AI-driven solutions and...
The Medtronic Sphere-360โข Pulse Field Ablation (PFA) catheter, a new paradigm in single-shot ablation, demonstrates impressive results in treating paroxysmal atrial fibrillation PR...
SMART trial one-year data demonstrates Medtronic Evolutโข TAVR platform as optimal treatment for severe aortic stenosis in patients with small annulus, which is primarily women Canada...
New survey uncovers lack of awareness around heart valve disease and risk factors among women PR Newswire DUBLIN, April 7, 2024 Despite prevalence of chronic conditions associated with aortic...
Medtronic announces FDA approval of newest-generation Evolut TAVR system for treatment of symptomatic severe aortic stenosis PR Newswire DUBLIN, March 27, 2024 The Evolutโข FX+ TAVR system...
U.S. Patent Office rejects Axonics' latest challenge to Medtronic patents PR Newswire DUBLIN, March 21, 2024 Medtronic moves for patent infringement litigation to resume DUBLIN, March 21, 2024ย ...
New real-world data shows MiniMedโข 780G system sustains strong global performance, exceeding international targets for diabetes management PR Newswire DUBLIN and FLORENCE, Italy, March 9, 2024...
Medtronic announces cash dividend for fourth quarter of fiscal year 2024 PR Newswire DUBLIN, March 7, 2024 Board authorizes $5 billion for share repurchases DUBLIN, March 7, 2024ย /PRNewswire/...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.06 | 0.0754432289702 | 79.53 | 81.34 | 78.78 | 5532866 | 80.13883987 | CS |
4 | -7.25 | -8.3486872409 | 86.84 | 87.18 | 78.43 | 6085040 | 81.79108251 | CS |
12 | -7.86 | -8.98799313894 | 87.45 | 88.25 | 78.43 | 6316661 | 83.89631608 | CS |
26 | 8.34 | 11.7052631579 | 71.25 | 89.18 | 68.84 | 6376032 | 81.57767575 | CS |
52 | -10.23 | -11.3894455578 | 89.82 | 92.02 | 68.84 | 5987369 | 82.16553272 | CS |
156 | -51.8 | -39.4246137453 | 131.39 | 135.89 | 68.84 | 5904473 | 93.79100269 | CS |
260 | -7.66 | -8.77936962751 | 87.25 | 135.89 | 68.84 | 5564136 | 97.45632721 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions